Have you been diagnosed with low-grade serous ovarian cancer (LGSOC)? If so, please consider participating in a short online survey. Your participation will help us gain further insight into this rare and difficult to treat disease so that we may better understand, support and call attention to the needs of those living with LGSOC.
Click here to see if you qualify for the survey.
This 15-minute online survey is being administered by The Harris Poll and is supported by Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer. Your individual responses will remain confidential and reported only in combination with the responses of others. Your email address and individual survey data will not be used for future marketing efforts and your information will not be sold.
Please note if you are accessing this page via a Facebook/Instagram/Messenger App you need to copy and paste https://bit.ly/lowgradesurvey into a web browser for the survey to work correctly.
